XORTX Therapeutics (XRTX) Q2 2025 Earnings

19MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-1.24
-0.81
-0.37
0.06

Details

Expected EPS
-0.27
Actual EPS
-0.19
Surprise EPS
0.08
Surprise Percent
+29.63%

Description

XORTX Therapeutics (XRTX) has reported earnings of -0.19 per share for Q2 2025.

0 Comments

Share your thoughts